Hosted on MSN3m
You thought only DeepSeek routed American titans? Wait, here's a little-known Chinese biotech company whose lung cancer drug could rattle big pharma; here's al…
This drug, developed and tested in China, shocked the industry when it outperformed Keytruda, Merck’s cancer drug, as per the ...
Pharmaceutical Technology18m
Eikon raises almost $351m to advance cancer candidates through the clinic
Eikon’s lead candidate EIK1001 is being investigated for melanoma in combination with MSD’s Keytruda in a Phase III trial.